Education

• Postdoctoral fellow (Immunology, MD Anderson Cancer Center (advisor: Chen Dong), USA)
• Ph.D. (Immunology, Seoul National University, (advisor: Chang-Yuil Kang), Korea)
• MS (Immunology, Seoul National University, Korea)
• BS (Pharmacy, Seoul National University, Korea)

Professional Experience

• 2026-present (Director, Center for Viral Immunology, Institute for Basic Science (IBS), Korea)
• 2014-present (assist/assoc/full professor, Seoul National University, Korea)
• 2020-2026 (Director, Leader research center for immunolipid metabolism, Korea)
• 2010-2014 (assistant professor, University of Texas, USA)

Honors and Awards

• 2014 Herbert Tabor Young Investigator Award, International Cytokine & Interferon Society
• 2018 1stKAI-Genexine Excellence Award, Korean Association of Immunologists
• 2019 Top 100 National R&D Excellence Achievements
• 2025 Commendation from the Minister of Health and Welfare
• 2025 Commendation from the Minister of Science and ICT

Research Interests

• Aging and immunosenescence, diversity and plasticity of T cell, longevity of immune cell, immunometabolism, host defense against infection, immunotherapeutics

Publications (Max 5)

• NRF2 is a spatiotemporal metabolic hub essential for the polyfunctionality of Th2 cells. PNAS. 2024. 121:e2319994121
• A personalized cancer vaccine that induces synergistic innate and adaptive immune responses. Advanced Materials. 2023. 35:e2303080
• Atherogenic dyslipidemia promotes autoimmune follicular helper T cell responses via IL-27. Nature Immunology. 2018. 19:583
• Proatherogenic conditions promote autoimmune T helper 17 cell responses in vivo. Immunity. 2014. 40:153
• Follicular regulatory T cells expressing Foxp3 and Bcl6 suppress germinal center reactions. Nature Medicine.2011. 17: 983